Sylvie Murgo

Sylvie Murgo has worked as an IP Director since 2006, beginning with Fovea Pharmaceuticals. Sylvie then moved on to Transgene in the same role in 2006. In 2013, they took on the same role at GenSight Biologics and Pixium Vision S.A. Sylvie then moved to BrainEver and PROPHESEE in 2015, both in the same role. In 2016, they began working as an IP Director at Tilak Healthcare, Chronolife, and iBionext.

Sylvie Murgo attended Strasbourg University from 1986 to 1991, where they earned a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology. Sylvie then attended CEIPI from 1992 to 1993.